The recommendations provided in this document represent a distillation of various experiences, as well as data obtained from published studies in the setting of substantial changes in antibiotic sensitivity. It is hoped that this revised compilation will provide a basis upon which future developments and advances can be made in the therapeutic approach to infectious complications of peritoneal dialysis.
Get full access to this article
View all access options for this article.
References
1.
BailieG.R., EiseleG.Pharmacokinetic issues in the treatment of CAPD peritonitis.J Antimicrab Chemather1995; 35: 563–7.
2.
BarzaM., IoannidisJ.P.A., CappelleriJ.C., LauJ.Single or multiple daily doses of aminoglycosides: a meta-analysis.BMJ1996; 312: 338–45.
3.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylacaccus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.Am J Kidney Dis1996; 27: 695–700.
ChanM.K., ChanP.C.K., ChengI.P.K.Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment.Nephral Dial Transplant1989; 4: 814–17.
7.
ChengI.K.P., FangGX, ChanT.M.Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment.QJ Med1989; 71: 407–16.
8.
ChurchillD.N., TaylorD.W., VasS.I.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the y connector disinfectant system to standard systems.Perit Dial Int1989; 9: 159–63.
9.
Coles GA, for the Mupirocin Study Group.The effect of intranasal mupirocin on CAPD exit site infection (ESI).J Am Sac Nephral1994; 5: 439.
10.
Working Party of the British Society for Antimicrobial Chemotherapy.Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis.Lancet1987; i: 845–8.
11.
EisenbergE.S., LevitonI., SociroR.Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature.Rev Infect Dis1986; 8: 309–21.
12.
FineR.N., SaluskyI.B., HallT., LuculloL., JordanS.C., EttengerR.B.Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.Pediatrics1983; 71: 806–9.
GovaertsP.J., ClaesJ., Van De HeyningP.H., JorensP.G., MarquetJ., De BroeM.E.Aminoglycoside induced ototoxicity.Taxical Lett1990; 52: 227–51.
16.
InnesA., BurdenR.P., FinchR.G., MorganA.G.Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double blind trial.NephrolDial Transplant1994; 9: 797–9.
17.
KlausG., SchaeferF., Müller-WiefeID., MehlsO.for the Arbeitgemeinschaft Pädiatrische Nephrologie. Treatment of peritoneal dialysis -associated peritonitis with continuous versus intermittent vancomycin/teico-planin and ceftazidime in children: preliminary results of a prospective randomized trial. In: KhannaR. ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications Inc., 1995; 11: 296–301.
18.
KuizonB., MelocotonT.L., HollowayM.Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution.Pediatr Nephral1995; 9(Suppl): S12–17.
19.
LomaestroB.M., BailieG.R.Absorption interactions with fluoroquinolones: 1995 update.Drug Saf1995; 12: 314–37.
20.
LowC.L., BailieG.R., EvansA., EiseleG., VeneziaR.A.Pharmacokinetics of once-daily ip gentamicin in CAPD patients.Perit Dial Int1996; (in press).
21.
LumG.M.Peritonitis in infants and children on CAPD/CCPD. In: AnderiottiV.E., FineR.N. eds. Topics in renal medicine. VoI. 4. Chronic ambulatory peritoneal dialysis (CAPD) and chronic cycling peritoneal dialysis (CCPD) in children.Amsterdam: Martinius Nijhoff;1987: 189–200.
22.
LuzarM.A., BrownC.B., BalfD.Exit site care and exit site infection in CAPD: results of a randomized multicenter trial.Perit Dial Int1990; 10: 25–9.
23.
MillikinS.P., MatzkeG.R., KeaneW.F.Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.Perit Dial Int1991; 11: 252–60.
PagniezD., MacNamaraE., FortinF.Withdrawal of continuous ambulatory peritoneal dialysis to treat mild peritonitis.BMJ1988; 297: 1174–5.
29.
PetersonP.K., MatzkeG.R., KeaneW.F.Current concepts in the management of peritonitis in continuous ambulatory peritoneal dialysis patients.Rev Infect Dis1987; 9: 604–12.
30.
PirainoB., BernardiniJ., SorkinM.A five-year study of the microbiologic results of exit -site infections and peritonitis in continuous ambulatory peritoneal dialysis.Am J Kidney Dis1987; 10: 281–6.
31.
PrinsJ.M., BüllerH.R., KuijperE., TangeR.A., SpeelmanP.Once-daily gentamicin versus once-daily netilmicin in patients with serious infections-a randomized clinical trial.J Antimicrab Chemother1994; 33: 823–35.
32.
RubinJ., RogersW.A., TaylorH.M.Peritonitis during continuous ambulatory peritoneal dialysis.AnnInternMed1980; 92: 7–13.
33.
SewellD.L., GolperT.A., HulmanP.B.Comparison of large volume culture to other methods for isolation of microorganisms from dialysate.Perit Dial Int1990; 10: 49–52.
34.
SpencerR.C.Infections in continuous ambulatory peritoneal dialysis.J MedMicrabial1988; 27: 1–9.
35.
SwartzR., MessanaJ., ReynoldsJ., RanjitU.Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections.Kidney Int1991; 40: 1160–5.
36.
TranaeusA., HeimburgerO., LindholmB.Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): risk factors, clinical severity, and pathogenetic aspects.Perit Dial Int1988; 8: 253–63.
37.
VasS.I.Microbiologic aspects of chronic ambulatory peritoneal dialysis.Kidney Int1983; 23: 83–92.
38.
VasS.I.Peritonitis. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.4th ed.Dordrecht: Kluwer Academic Publishers, 1994: 473–501.
39.
VasS.I.Renaissance of tuberculosis in the 1990s: lesson for the nephrologist.Perit Dial Int1994; 14: 209–14.
40.
WaradyB.A., CampoyS.F., GrossS.P., SedmanA.B., LumG.M.Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.J Pediatr1984; 105: 726–30.
41.
WaradyB.A., SullivanE.K., AlexanderS.R.Lessons from the peritoneal dialysis patient data base: a report of the North American Pediatric Renal Transplant Cooperative Study.Kidney Int1996; 49(Suppl 53): S68–71.
42.
WatsonA.R., VigneauxA., BannatyneR.M., BalfeJ.W.Peritonitis during continuous ambulatory peritoneal dialysis in children.Can Med Assoc J1986; 134: 1019–22.
43.
WilliamsA.J., BoeltisI., JohnsonB.F.Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.Perit Dial Int1989; 9: 65–7.
44.
ZárubaK., PetersJ., JungbluthH.Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience.Am J Kidney Dis1991; 17: 43–6.
45.
ZimmermanS.W., AhrensE., JohnsonC.A.Randomized controlled trial of prophylactic rifampin for peritoneal dialysis related infections.Am J Kidney Dis1991; 18: 225–31.
